Prevention of liver cancer cachexia-induced cardiac wasting and heart failure

Springer, Jochen, Tschirner, Anika, Haghikia, Arash, von Haehling, Stephan, Lal, Hind, Grzesiak, Aleksandra, Kaschina, Elena, Palus, Sandra, Pötsch, Mareike, von Websky, Karoline, Hocher, Berthold, Latouche, Celine, Jaisser, Frederic, Morawietz, Lars, Coats, Andrew J S, Beadle, John, Argiles, Josep M, Thum, Thomas, Földes, Gabor, Doehner, Wolfram, Hilfiker-Kleiner, Denise, Force, Thomas and Anker, Stefan D (2014) Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. European Heart Journal, 35 (14). pp. 932-941. ISSN 0195-668X

Full text not available from this repository.


Symptoms of cancer cachexia (CC) include fatigue, shortness of breath, and impaired exercise capacity, which are also hallmark symptoms of heart failure (HF). Herein, we evaluate the effects of drugs commonly used to treat HF (bisoprolol, imidapril, spironolactone) on development of cardiac wasting, HF, and death in the rat hepatoma CC model (AH-130).

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 24 Jan 2014 12:44
Last Modified: 24 Oct 2022 05:48
DOI: 10.1093/eurheartj/eht302

Actions (login required)

View Item View Item